Evidence map›Paper›PMID 37855329›Full record

ReviewEndocrine connections2023

Relationship between serum uric acid levels and osteoporosis.

Rong Xu, Difei Lian, Yan Xie, Lin Mu, Yali Wu, Zhilei Chen, Baoyu Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Endocrine connections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rong XuCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Difei LianCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Yan XieCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Lin MuCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Yali WuCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Zhilei ChenCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
Baoyu ZhangCenter for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-4751-7608
Capital Medical University · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis (OP) is a systemic bone disease in which bone density and quality decrease and bone fragility increases due to a variety of causes, making it prone to fractures. The development of OP is closely related to oxidative stress. Uric acid (UA) is the end product of purine metabolism in the human body. Extracellular UA has antioxidant properties and is thought to have a protective effect on bone metabolism. However, the process of UA degradation can lead to intracellular oxidative stress, which together with UA-induced inflammatory factors, leads to increased bone destruction. In addition, UA can inhibit vitamin D production, resulting in secondary hyperparathyroidism and further exacerbating UA-associated bone loss. This review summarizes the relationship between serum UA levels and bone mineral density, bone turnover markers, and so on, in the hope of providing new insights into the pathogenesis and treatment of OP.

Indexed as

bone metabolismgouthyperuricemiaosteoporosisuric acid

Identifiers

PMID37855329
PMCPMC10620457
OpenAlexW4386817397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.